Survey results highlight the need for concerted action to guard against a fresh upsurge in the disease.
The culture of volunteerism is a fundamental part of the Novartis corporate ethos. Here’s a snapshot of our efforts over the years.
One man’s fascination with malaria helps fuel the search for new treatments
The best treatment for multifaceted diseases like NASH may be combinations of drugs.
Novartis researchers are using new technologies, such as DNA-encoded libraries, to find new ways to treat disease.
The disease hobbles families and economies.
Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.
COPD receives low attention as a women’s health issue. It’s time to change that.
Novartis is developing an experimental drug for weight loss.
Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.